BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7712932)

  • 1. [Long-term treatment with quinapril in chronic aortic and mitral insufficiency].
    Schön HR; Schömig A
    Dtsch Med Wochenschr; 1995 Mar; 120(13):429-35. PubMed ID: 7712932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
    Schön HR
    J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinapril therapy in patients with chronic mitral regurgitation.
    Schön HR; Schröter G; Barthel P; Schömig A
    J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation.
    Schön HR; Dorn R; Barthel P; Schömig A
    J Heart Valve Dis; 1994 Sep; 3(5):500-9. PubMed ID: 8000584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation.
    Schön HR; Schröter G; Blömer H; Schömig A
    Am J Cardiol; 1994 Apr; 73(11):785-91. PubMed ID: 8160617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
    Levine HJ; Gaasch WH
    J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.
    Banaszewski M; Rydlewska-Sadowska W; Rubkiewicz S
    J Heart Valve Dis; 1998 Sep; 7(5):488-99. PubMed ID: 9793844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation.
    Wisenbaugh T; Sinovich V; Dullabh A; Sareli P
    J Heart Valve Dis; 1994 Mar; 3(2):197-204. PubMed ID: 8012639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of volume load of the left ventricle in aortic and mitral insufficiency on the geometry and function of the right ventricle].
    Unterberg R; Römmich P; Völker W; Mauser M; Karsch KR
    Z Kardiol; 1987 Dec; 76(12):761-9. PubMed ID: 3439251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of chronic valvular regurgitation.
    Schön HR
    J Heart Valve Dis; 1995 Oct; 4 Suppl 2():S170-4. PubMed ID: 8563994
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study.
    Mori Y; Nakazawa M; Tomimatsu H; Momma K
    J Am Coll Cardiol; 2000 Jul; 36(1):270-5. PubMed ID: 10898445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy.
    Lin M; Chiang HT; Lin SL; Chang MS; Chiang BN; Kuo HW; Cheitlin MD
    J Am Coll Cardiol; 1994 Oct; 24(4):1046-53. PubMed ID: 7930196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up of patients with chronic aortic valve insufficiency with ACE inhibitor therapy].
    Weyer C; Mohr-Kahaly S; Erbel R; Meyer J
    Z Kardiol; 1997 Dec; 86(12):1010-6. PubMed ID: 9499499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regurgitant volume informs rate of progressive cardiac dysfunction in asymptomatic patients with chronic aortic or mitral regurgitation.
    Kusunose K; Cremer PC; Tsutsui RS; Grimm RA; Thomas JD; Griffin BP; Popović ZB
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):14-23. PubMed ID: 25499130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy.
    Pisacane C; Pacileo G; Santoro G; Sarubbi B; Iacono C; Russo MG; Calabrò R
    Ital Heart J; 2001 Feb; 2(2):100-6. PubMed ID: 11256536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors in pediatric patients with mitral valve regurgitation-case-control study and review of the literature.
    Knirsch W; Tlach L; Stambach D; Bauersfeld U
    Congenit Heart Dis; 2010; 5(3):278-84. PubMed ID: 20576047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term captopril therapy in asymptomatic patients with severe chronic aortic insufficiency].
    Bisignani G; Serafini O; Caporale R; Guzzo D; Plastina F
    G Ital Cardiol; 1997 Sep; 27(9):925-30. PubMed ID: 9378199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term evaluation of captopril in patients with chronic left sided valvular regurgitations.
    Jirasirirojanakorn K; Mahanonda N; Jootar P; Chaithiraphan S; Wansanit K; Watanaprakarnchai W
    J Med Assoc Thai; 1998 Jan; 81(1):1-9. PubMed ID: 9470315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationships between left ventricular volumes and ejection fraction in mitral and aortic regurgitation (author's transl)].
    Strauer BE; Kramer H; Bolte H; Riecker G
    Klin Wochenschr; 1975 Oct; 53(20):795-84. PubMed ID: 1202276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.